ClearPoint Neuro, Inc.
CLPT
$10.32
-$0.2114-2.01%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.88% | -8.28% | -12.84% | -6.32% | 10.24% |
| Total Depreciation and Amortization | -29.09% | -4.85% | 6.91% | -2.32% | 11.79% |
| Total Amortization of Deferred Charges | -- | -100.00% | 57.14% | -6.67% | 0.00% |
| Total Other Non-Cash Items | 11.02% | 0.53% | 32.68% | 5.67% | -28.45% |
| Change in Net Operating Assets | -248.18% | 29.84% | 887.21% | 88.84% | -238.45% |
| Cash from Operations | -396.54% | -3.67% | 55.06% | 30.52% | -228.49% |
| Capital Expenditure | 30.42% | -2,091.67% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 30.42% | -2,091.67% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -82.64% | -- | -100.00% | -98.22% | 8,339.58% |
| Repurchase of Common Stock | -1,453.57% | -37.70% | 52.34% | 15.23% | -308.11% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3,781.08% | 100.37% | -6,388.13% | -99.00% | 10,256.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -425.32% | 86.97% | -349.44% | -120.54% | 1,116.06% |